Making Medication Therapy Management a Cornerstone of Community-Based Care for People with Alzheimer's Disease and Other Forms of Dementia

By Center, Medicare Rights | Care Management Journals, July 1, 2007 | Go to article overview

Making Medication Therapy Management a Cornerstone of Community-Based Care for People with Alzheimer's Disease and Other Forms of Dementia


Center, Medicare Rights, Care Management Journals


Editor's Note. The following document reports on research conducted in 2006 and is reprinted and adapted for the Care Management Journals format with permission from the Medicare Rights Center (www.medicarerights.org).

People with Alzheimer's disease and other forms of dementia have a particular need for medication therapy management (MTM) services that improve compliance with drug regimens and address inappropriate prescribing. All Medicare Part D plans are required to establish MTM programs, but plans have generally favored eligibility criteria, modes of delivery, and enrollment models that are ill suited to people with dementia. The Centers for Medicare and Medicaid Services (CMS) should take a proactive stance to encourage the development of MTM programs that meet the needs of people with Alzheimer's disease and other forms of dementia, particularly those who reside in the community.

Every year the United States spends over $200 billion to correct medication-related problems. 1 Some patients do not take their medicine as prescribed; some are treated with too much, too little, or the wrong medicine; and some are prescribed medicines that interact dangerously with each other (Table 1). As a result, as many as 200,000 people in the United States may die from medication-related problems each year 2 and 16% of all hospital admissions are due to medication-related problems.3

The burden of advancing age and increasing incidence of chronic illness makes older adults particularly vulnerable to these medication-related problems. On average, they are taking more medications and many are becoming less able to manage them. The Office of Inspector General of the Health and Human Services Department reports that 55% of older adults fail to comply in some way with their medication regimen.4 Nearly 28% of hospital admissions for people age 65 and older are due to medication-related problems.5 Moreover, medication-related problems are estimated to be one of the top five causes of death in that age group.6 One quarter of all nursing home admissions result from older people being unable to take their medications properly.7

These challenges are amplified for people with diminished capacity to make sound health care decisions, such as those with Alzheimer's disease or dementia. Alzheimer's disease, a progressive brain disorder that results in a gradual and steady deterioration of mental ability, can make it impossible for a person to manage his or her medication. Dementia was identified by the Office of Inspector General as one of the dominant reasons older adults fail to comply with their medication regimens.8 Similarly, a survey commissioned by the Mental Health Foundation of the United Kingdom found that over 90% of people with dementia who were living in the community suffered from medicationrelated problems.9 The financial and social implications of this are devastating.

In the United States, at least $100 billion is spent each year on Alzheimer's disease, with the average lifetime cost of care for an individual with Alzheimer's disease estimated at $174,000 in 1991.10 The average annual direct cost of care in 1998 was $19,000 per individual still in the community and $64,000 per institutionalized individual. 11 Further, most individuals with Alzheimer's disease eventually spend part of their lives in a nursing home or assisted living facility.

The comprehensive approach of MTM could play a crucial role in optimizing therapeutic outcomes for people with dementia and lead to reduced overall health care expenditures. The provision of MTM services for this population could optimize the use of medicines that slow the rate of mental decline, minimize the use of drugs that worsen dementia, as well as the inappropriate use of drug therapy to address behavioral symptoms of Alzheimer's disease. The application of MTM can also help with compliance with drug regimens, potentially delaying the need for long-term care services. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Making Medication Therapy Management a Cornerstone of Community-Based Care for People with Alzheimer's Disease and Other Forms of Dementia
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.